Last Price
0.388
Today's Change
+0.051 (15.13%)
Day's Change
0.362 - 0.437
Trading Volume
37,182,219
Profile
CTCX
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Ms. Kendra Bracken-Ferguson Ms. Kendra Bracken-Ferguson
Full Time Employees: 9 9
IPO Date: 2021-09-23 2021-09-23
CIK: 0001842939 0001842939
ISIN: US1429221039 US1429221039
CUSIP: 142922103 142922103
Beta: 0.29 0.29
Last Dividend: 0.00 0.00
Dcf Diff: 0.31 0.31
Dcf: 0.07 0.07
Description
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Global Investors Are Hoarding Cash to Bet on Taiwan's AI Return
2
CEO Morning Brief
Trump Threatens 200% Tariff on Vehicles Imported From Mexico
3
CEO Morning Brief
Southeast Asian Scammers Stole Up to US$37b in 2023, UN Says
4
CEO Morning Brief
Buffett’s Bank of America Stock Selling Spree Surpasses US$10b
5
CEO Morning Brief
Fed’s Musalem Argues for More Rate Cuts, Says Data to Drive Easings
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
